[1]
|
D. Sahoo, S. Sahoo, P. Mohanty, S. Sasmal, P.L. Nayak, “Chitosan: a new versatile biopolymer for various applications, ” Designed Monomers and Polymers, Vol. 12, 2009, 377-404,.
|
[2]
|
S. Sahoo, A. Sasmal, R. Nanda, A.R. Phani, P.L. Nayak, “Synthesis of chitosan-poly bhisek Sasmal, caprolactone blend for control delivery of ofloxacin drug,” Carbohydrate Polymers, Vol. 79, 2010,106-113.
|
[3]
|
S.K. Mallapragada, N.A. Peppas, “Dissolution mechanism of semicrystalline poly (vinyl alcohol) in water,” J Polym Sci: Part B, Polym. Physics Vol. 34, 1996, 1339- 1349.
|
[4]
|
G. Paradossi, R. Lisi, M. Paci, V. Crescenzi, “New hydrogels based on poly (vinyl alcohol),” J. Polym Sci., Part A , Polym. Chem, Vol. 34, 1996, 3417-3495.
|
[5]
|
J. Jegal, K. Lee, “Nanofilteration membranes based on poly (vinyl alcohol) and ionic polymers,” J Appl Polym. Sci, Vol. 72, 1999, 1755-1762.
|
[6]
|
T. Chandy, C.P. Sharma, “Prostaglandin E1- immobilized poly (vinyl alcohol) -blended chitosan membranes: Blood compatibility and permeability properties,” J Appl. Polym. Sci, Vol. 44, 1992, 2145-2156.
|
[7]
|
J. Mathew, M. Kodama, “Study of blood compatible polymers I. modification of poly (vinyl alcohol),” Polym. J , Vol. 24, 1992, 31- 41.
|
[8]
|
U. Edlund, & A.C. Albertsson, “Degradable Polymer Microspheres for Controlled Drug Delivery,” Advances in Polymer Science, Vol. 157, 2002, 67-112.
|
[9]
|
A. Rajeev Jain, “The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices,” Biomaterials, Vol. 21, 2000, 2475.
|
[10]
|
K.R. Kamath and K. Park, “Biodegradable hydrogels in drug delivery,” Advanced Drug Delivery Reviews, Vol. 11, 1993, 59-84.
|
[11]
|
A.G. Mikos, M.D. Lyman, L.E. Freed, & R. Langer, “Wetting of poly(L-lactic acid) and poly (DL-lactic-co- glycolic acid) foams for tissue culture,” Biomaterials, Vol. 15(1), 1994, 55-58.
|
[12]
|
H.S. Kas, “Chitosan: properties, preparation and application to microparticulate systems,” Journal of Microencapsulation , Vol. 14 (6), 1997, 689-711.
|
[13]
|
T. Chandy & C.P. Sharma, “Chitosan as a biomaterial, Artificial Cells, Blood Substitutes,” Biotechnology: An International Journal, Vol. 18, 1990, 1-24.
|
[14]
|
H. Fukuda, “Polyelectrolyte Complexes of Chitosan with Sodium Carboxymethylcellulose,” Bulletin of the Chemi- cal Society of Japan, Vol. 53 (4), 1980, 837-840.
|
[15]
|
Y. Kato, H. Onishi, & Y. Machida, “Application of chitin and chitosan derivatives in the pharmaceutical field,” Current Pharmaceutical Biotechnology, Vol. 4, 2003, 303-309.
|
[16]
|
B. Gibbs Jackson, “Mechanism-Based Target Identifica- tion and Drug Discovery in Cancer Research,” Science, Vol. 287, 2000, 1969-1973.
|
[17]
|
P. Mankad, J. Spatenka, Z. Slavik, G. Oneil, A. Chester, & M. Yacoub, “Acute Effects of Cyclosporine and Cr EL on Endothelial Function and Vascular Smooth Muscle in the Isolated Rat-Heart,” Cardiovascular Drugs and Therapy, Vol. 6(1), 1992, 77-83.
|
[18]
|
T. M. Aminabhavi, & H. G. Naik, “Chemical compatibility study of geomembranes-sorption/desorption, diffusion and swelling phenomena,” Journal of Hazardous Materials, Vol. 60, 1998, 175-203.
|
[19]
|
D. Sahoo, S. Sahoo, J. Das, T.K. Dangar, P.L. Nayak., “Antibacterial Activity of chitosan crosslinked with Aldehydes and blended with Cloisite 30B,” NanoTrends , Vol 10, 2011, 01-09.
|
[20]
|
T. Sekine, K. Yoshida, F. Matsuzaki, T. Yanaki, & M. Yamaguchi, “A novel method for preparing oil-in water- in-oil type multiple emulsions using organophilic montmorillonite clay mineral,” Journal of Surfactants and Detergents, Vol 2 (3), 1999, 309-15.
|
[21]
|
A. Goel, B.A. Kunnumakkara, B.B. Aggarwal, “Curcu- min as “Curecumin”from kitchen to clinic (commentary),” Biochem Pharmacol, Vol 75, 2008, 787-809.
|
[22]
|
M.N. Sreejayan Rao, “Nitric oxide scanvenging by curcuminoids,” J Pharm Pharmacol, Vol 49, 1997, 105-107.
|
[23]
|
H.P. Ammon, M.A. Wahl, “Pharmacology of Curcuma longa,” Planta Med, Vol 57, 1991, 1-7.
|
[24]
|
I. Brouet, H. Ohshima, “Curcumin, An anti-tumour pro- moter and antiimflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages,” Biochem Biophys Res Commun, Vol 206, 1995, 533-40.
|
[25]
|
M. Dikshit, L. Rastogi, R. Shukla, R.C. Srimal, “Preven- tion of ischaemiainduced biochemical changes by curcumin and quinidine in the cat heart,” Ind J Med Res, Vol 101, 1995, 31-50.
|
[26]
|
M.M. Yallapu, M. Jaggi and S.C.Chauhan, “β-Cyclodex- trin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells Original Research Article,” Colloids and Surfaces B: Biointerfaces, Vol. 79, 2010, 113- 125.
|
[27]
|
K.Varaprasad, Y. M.Mohan, K. Vimala and K. M. Raju, “Synthesis and characterization of hydrogel-silver nano- particle-curcumin composites for wound dressing and an- tibacterial application,” Journal of Applied Polymer Sci- ence, Vol. 121, 2011, 784-796.
|
[28]
|
C.V. Rao, A. Rivenson, B. Simi, B.S. Reddy, “Chemo- prevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound,” Cancer Res, Vol 55, 1995, 259-266.
|
[29]
|
Y. Kiso, Y. Suzuki, N. Watanabe, Y. Oshima, H. Hikino, “Antihepatotoxic principles of Curcuma longa rhizomes,” Planta Med, Vol 49, 1983, 185-187.
|
[30]
|
H.H. Tonnesen, J. Karlsen, “Studies on curcumin and curcuminoids. VI. Kinetics of curcumin degradation in aqueous solution,” Z Lebensm Unters Forsch, Vol 180, 1985, 402-404.
|
[31]
|
A. Kunwar, A. Barik, R. Pandey, K.I. Priyadarsini, “Transport of liposomal and albumin loaded curcumin to living cells; an absorption and fluorescence spectroscopic study,” Biochim Biophys Acta, Vol 1760, 2006, 1513- 1520.
|
[32]
|
K. Vidyalakshmi K. N. Rashmi, T. M. Pramod Kumar, Siddaramaiah, “Studies on Formulation and In Vitro Evaluation of PVA/Chitosan Blend Films for Drug Delivery,” Journal of Macromolecular Science w Part A—Pure and Applied Chemistry, Vol. A41, 2004, 1115- 1122.
|
[33]
|
K. Vimala, Y. M. Mohan, K.Varaprasad, N. N. Redd, S. Ravindra, N.S.Naidu, K.M.Raju, Fabrication of Cur- cumin Encapsulated Chitosan-PVA Silver Nanocompo- site Films for Improved Antimicrobial Activity,” Journal of Biomaterials and Nanobiotechnology, Vol. 2, 2011, 55-64.
|
[34]
|
M.M. Yallapu, B.K. Gupta, M. Jaggi and S.C.Chauhan, “Fabrication of curcumin encapsulated PLGA nanoparti- cles for improved therapeutic effects in metastatic cancer cells Original Research Article,” Journal of Colloid and Interface Science, Vol. 351, 2010, 19-29.
|
[35]
|
G. Xu, & H. Sunada, “Influence of Formation changes on drug release kinetics,” Chemical & Pharmaceutical Bulletin, Vol 43, 1995, 483-487.
|
[36]
|
T. Higuchi, “Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices,” Journal of Pharmaceutical Sciences, Vol 52 (12), 1963, 1145-1149.
|
[37]
|
A. R. Kulkarni, K. S. Soppimath, & T. M. Aminabhavi, “Controlled release of diclofenac sodium from sodium alginate beads crosslinked with glutaraldehyde,” Phramaceutica Acta Helvitae , Vol. 74, 1999, 29-36.
|
[38]
|
R. L. Ritger, & N.A. Peppas, “A simple equation for dis- position of solute release-II,” Journal of Controlled Release, Vol. 5, 1987, 37-42.
|
[39]
|
A.K. Singla, A. Garg & D. Aggarwal, “Paclitaxel and its formulations,” International Journal of Pharmaceutics, Vol. 235 (1), 2002, 179-192.
|
[40]
|
A.K. Singla, & M. Chawla, “Chitosan: some pharmaceutical and biological aspects—an update,” Journal of Pharmacy and Pharmacology, Vol. 53 (8), 2001, 1047- 1067.
|